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Abstract
Objective Digital X-ray radiogrammetry (DXR) calculates
peripheralbonemineraldensity(BMD)fromhandradiographs.
The short-term precision for direct DXR has been reported to
be highly satisfactory. However, long-term precision for this
method has not been examined. Thus, the aim of this study was
to examine the long-term in-vitro precision for the new direct
digital version of DXR.
Materials and methods The in-vitro precision for direct
DXR was tested with cadaver phantoms on four different
X-ray systems at baseline, 3 months, 6 months, and in one
machine also at 12 months. At each time point, 31
measurements were performed.
Results The in-vitro longitudinal precision for the four
radiographic systems ranged from 0.22 to 0.43% expressed
as coefficient of variation (CV%). The smallest detectable
difference (SDD) ranged from 0.0034 to 0.0054 g/cm
2.
Conclusions The in vitro long-term precision for direct
DXR was comparable to the previous reported short-
term in-vitro precision for all tested X-ray systems.
These data show that DXR is a stable method for detecting
small changes in bone density during 6–12 months of
follow-up.
Keywords Digital X-ray radiogrammetry.Precision.
Rheumatoid arthritis.Osteoporosis.Bone mineral density
Introduction
Bone densitometry is central for the diagnosis and manage-
ment of osteoporosis. Several methods for measurement of
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digital X-ray radiogrammetry (DXR). DXR calculates BMD
at metacarpal hand bones from digital radiographs. DXR-
measured bone density has been shown to be a good predictor
of fractures [1, 2] and in rheumatoid arthritis (RA) to be a
sensitive measure of inflammatory bone involvement [3, 4].
The ability to monitor change is dependent upon the
longitudinal reproducibility (precision). The short-term
reproducibility for DXR, both in vitro and in vivo has been
reported to be in the range 0.14 to 0.30 expressed as
coefficient of variation (CV) [5]. For long-term follow-up,
uncorrected equipment drift may have a significant impact
on the accuracy and precision of the measurements [6].
Long-term precision for the DXR method has previously not
been studied. Thus our aim was to explore the long-term
in-vitro reproducibility for DXR-hand BMD.
Materials and methods
Direct DXR calculates BMD from digital hand radiographs,
which is a further development of DXR [7, 8], a computer
version of the traditional radiogrammetry technique [9]. All
the digital radiographs were analyzed by the same computer
software program, the online service of the manufacturer
(DXR-online, Sectra, Linköping, Sweden). To measure
online DXR-BMD, the system requires hand radiographs
from a digitized X-ray system with known resolution. The
computer automatically identifies regions of interest (ROI)
around the narrowest part of the second, third, and fourth
metacarpal bones on hand radiographs and measures
cortical thickness, bone width, and porosity in the region.
DXR-BMD is defined as: c x VPAcomb x (1-p), where c is a
density constant, VPA is volume per unit area, and p is
porosity.
The long-term in-vitro precision for direct DXR was
tested on four different X-ray systems from different
manufacturers located at three different centers (Kristiansand
and Trondheim in Norway and Helsingborg in Sweden). We
used three different cadaver forearm phantoms for the in-vitro
precision test, one at each center. For all four X-ray systems
the phantom hand DXR-BMD was measured 31 times with
repositioning of the phantom between each radiograph. This
procedure was performed at baseline, 3 months, 6 months,
andinKristiansandalsoafter12months.The followingX-ray
systems (computed radiography (CR)/ digital radiography
(DR);filmfocusdistance(FFD);tubevoltage;exposuredose)
were tested: in Kristiansand Fuji FCR XG1 (Fujifilm
Corporation, Tokyo; Japan) (CR, 100 cm; 50 kV; 5 mAs), in
Trondheim Agfa ADC Compact plus (Agfa-Gevart N.V.,
Mortsel, Belgium) (CR, 100 cm; 50 kV; 5 mAs) and in
Helsingborg we tested both the Fuji FCR Profect (Fujifilm
Corporation, Tokyo; Japan) (CR,100 cm, 40 kV; 8 mAs) and
Sectra MicroDose D40 (Sectra, Linköping, Sweden) (DR,
66 cm built-in; 35 kV; 10 mAs) (Table 1).
The X-ray systems were in clinical use at the different
hospitals with their own maintenance and quality assurance
(QA) procedures. The X-ray tube of the Sectra MicroDose
was changed between baseline and 3 months.
Statistics
Precision measures were estimated separately for each of
the four X-ray systems. At each time point j we measured
the short-term precision in terms of the standard deviation
SD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ Pnj
i¼1 ðxij   x jÞ
2=ðnj   1Þ
q
, and the coefficient of
variation CV%shortterm ¼ð SD=x jÞ 100. To estimate the
long-term precision, we used an extension of the traditional
Bland–Altman method, a one-way ANOVA random effects
model, xij ¼ m þ Aj þ "ij where the two last terms have
standard deviations sA and s", and represent between
follow-up and within follow-up variation, respectively. This
gives CV%longterm ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2
A þ s2
"
p
=xtotal. The smallest detect-
able difference (SDD) was identified using the Bland–
Altman 95% limits of agreement method [10] with
SDdiff ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2sA
2 þ 2s"
2
p
. Since this is a phantom measure-
ment, no true change is expected, thus d is expected to be 0
and SDD ¼ 1:96SDdiff.
Statistical analyses were performed with SPSS version
15 (SPSS Inc., Chicago, IL, USA) and Excel (Microsoft
Office, Microsoft Corporation, Redmond, WA, USA).
Results
The mean BMD values for the tested phantoms and the in-
vitro precision data (CV%short term, SD, CV%long term and
SDD) for the four X-ray systems are shown in Table 1.
The CV%long term ranged from 0.22 to 0.43%. The
precision data for Fuji FCR XG1 system in Kristiansand
remained stable also over the 12-month period: CV% 0.35
and SDD 0.0046 g/cm
2 both after 6 months and 12 months.
Among the four systems, those systems with higher
resolution resulted in better long-term precision expressed
as lower CV% ( Table 1 and Fig. 1).
Discussion
Using a cadaver study, we have shown that DXR is
robust and stable for measurements of BMD over a
follow-up time of 6 and 12 months. The in-vitro
precision (CV%) over 6 months for the four systems
ranged from 0.22 to 0.43%, and for one system, no
difference in the long-term precision data was found
between 6 months and 12 months.
1576 Skeletal Radiol (2011) 40:1575–1579Table 1 Long-term in-vitro cadaver phantom precision for the direct DXR-BMD tested in four different X-ray systems over a period of 6 months
for all equipments and for Fuji FCR XG1 (Kristiansand) also tested at 12 months
X-ray equipment centre Resolution
mm/pixel
CV% “short time”,
0 months, 3 months,
6 months
Mean BMD value (g/cm
2) SD CV%
“long-term”
SDD
(g/cm
2)
0 month 3 month
6 month
total Between
follow-up sA
Within
follow-up s"
Fuji FCR XG1
Kristiansand
0.100 0.22 0.471 0.471 0.0009 0.0013 0.35 0.0046
0.39 0.469
0.24 0.471
0.21* 0.469* 0.470* 0.0010* 0.0013* 0.35* 0.0046*
Agfa ADC compact
plus Trondheim
0.114 0.44 0.455 0.455 0.0007 0.0018 0.43 0.0054
0.39 0.455
0.38 0.455
Fuji FCR profect
Helsingborg
0.050 0.14 0.546 0.547** 0.0008 0.0009 0.22 0.0034
0.17 0.547
0.17 0.547
Sectra MicroDose
Helsingborg
0.049 0.11 0.544 0.545** 0.0011 0.0006 0.24 0.0036
0.12 0.546
0.10 0.545
* Data from 12 months
**The same phantom was used for both equipments
SD = standard error; CV% = coefficient of variation; SDD = “Smallest detectable difference”
Fig. 1 Cadaver phantom bone mineral density (BMD) values in four
tested X-ray systems. Measurements at baseline, 3 months, and
6 months and for FujiXG (Kristiansand) also at 12 months (box-and-
whisker plot: the marked line shows the median, and the bottom and
top of the box show the lower and upper quartiles. Circles represent
single observations outside the range of the whiskers
Skeletal Radiol (2011) 40:1575–1579 1577Annual loss of DXR-BMD for RA patients has been
reported to range from 1.7% [4] to 10% in patients with
early RA [11]. Thus, the ability to detect small changes
using DXR based on the good precision reported here
means that a significant loss can be detected within a short
interval in RA patients with high disease activity. This may
be of clinical importance, as changes in DXR-BMD have
been shown to be strongly associated with markers of
disease activity, disease severerness, and to future radio-
graphic joint damage [4, 12–16]. While CV% is calculated
using the mean BMD, SDD gives an absolute estimation of
the random measurement error, which in our study was low
and ranged from 0.0034 to 0.0054 g/cm
2.
As the cadaver phantoms are fragile and cannot be sent
by mail, we were not able to test all cadaver phantoms on
all four X-ray machines, which is a limitation of our study.
However, this most likely only had a minor influence on the
results. The BMD level for all three cadaver phantoms were
in the middle range of BMD values seen in adult
individuals. Theoretically, more cadaver phantoms with a
broad range of BMD should have been tested. For dual-
energy X-ray (DXA), precision has been reported to be
better for higher BMD levels than for lower BMD levels
[17]. In a recently published short-term study, no major
differences in the DXR BMD precision were found
between high and low bone density [5]. Thus, the precision
for the DXR method seems to be less influenced by the
BMD level than DXA. In this same study, we reported that
different X-ray systems measured different values for the
DXR-BMD on the same phantom [5]. Although these
differences are small, they may have a significant influence
on individual bone density follow-up results. Thus, in
follow-up of a patient, the same X-ray system should be
applied to achieve the most reliable results.
For logistic reasons, we performed cluster measurements
at the different time points instead of daily measurements,
which is a limitation of our study. Everyday measure of the
phantom would have made it easier to observe if the
measured values were drifting as a trend over time or more
a stepwise shift after, e.g., change of the X-ray tube.
However, as depicted in Fig. 1, we found only minor
variations for the mean DXR-BMD values between the
various time points. Further for FujiXG1, we found no
difference in CV% or SDD between 6 and 12 months.
In previous DXR studies calculating bone density on
conventional hand X-rays, the precision did not seem to be
significantly influenced either by film brand, film focus
distance, or exposure level, but tube voltage may have an
influence [18, 19]. For the Sectra MicroDose X-ray
machine, the tube was changed between 0 and 3 months,
however, the voltage was 35 kV at all time points. This
change of X-ray tube did not appear to influence the
reproducibility of the BMD measurements (Fig. 1).
We conclude that in vitro long-term precision for direct
DXR is comparable to previously reported short-term in-vitro
precision data. The DXR method may thus be a potential
important research and clinical tool for follow-up of changes
in hand bone density, in particular for assessment of patients
with osteoporosis and RA.
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